Publication Ethics & Policies

Publication Policies

The American Journal of AI, Digital Transformation, and Regenerative Pharmacist (AJADTRP) is committed to maintaining the highest standards of academic integrity, transparency, and ethical publishing practices. All authors, reviewers, and editors are expected to adhere to the following policies:

1. Open Access Policy

  • AJADTRP follows an open-access model, ensuring that all published articles are freely accessible to researchers, academicians, industry professionals, and the general public.

  • Authors retain copyright while granting the journal rights to publish and distribute their work.

2. Peer Review Policy

  • All submissions undergo a double-blind peer review process to ensure fairness, objectivity, and quality.

  • Each manuscript is reviewed by at least two experts in the relevant field.

  • Final acceptance is based on originality, scientific rigor, clarity, and contribution to the field.

3. Plagiarism and Research Integrity

  • Manuscripts are screened for plagiarism using advanced detection software.

  • Any form of plagiarism, data fabrication, or unethical research practice will result in immediate rejection or retraction.

  • Authors must ensure that submitted work is original and unpublished elsewhere.

4. Authorship and Contributions

  • Authorship should reflect substantial contributions to the research, writing, and approval of the final manuscript.

  • All authors must disclose any conflict of interest and provide acknowledgments for funding or institutional support.

5. Ethics in Research

  • Studies involving human participants or animals must comply with international ethical guidelines.

  • Authors are required to provide ethical clearance certificates or institutional review approvals, where applicable.

6. Retraction and Correction Policy

  • Articles may be retracted or corrected if errors, ethical violations, or significant inaccuracies are discovered post-publication.

  • Retractions will follow COPE (Committee on Publication Ethics) guidelines.

7. Licensing and Copyright

  • Articles are published under a Creative Commons License (CC BY), allowing sharing and adaptation with proper attribution.

  • Authors retain ownership of their work while granting the journal permission to disseminate it globally.

8. Data Sharing and Transparency

  • Authors are encouraged to make data sets, codes, and methodologies available to support reproducibility and transparency.

  • Supplementary materials may be published alongside articles when relevant.

 

Ethics Policy

The American Journal of AI, Digital Transformation, and Regenerative Pharmacist (AJADTRP) is committed to upholding the highest standards of publication ethics and ensuring integrity in scholarly communication. The journal follows the principles of the Committee on Publication Ethics (COPE) and adheres to best practices in academic publishing.

1. Responsibilities of Authors

  • Authors must ensure their work is original, accurate, and free from plagiarism.

  • All data should be presented honestly without fabrication, falsification, or manipulation.

  • Proper acknowledgment of sources, funding, and institutional support must be provided.

  • Authorship should include only those who have made substantial contributions to the research.

  • Authors must declare any conflicts of interest that could influence the research.

2. Responsibilities of Reviewers

  • Reviewers must provide objective, fair, and timely evaluations of manuscripts.

  • They should maintain confidentiality of submitted works and not use information for personal advantage.

  • Reviewers must declare any conflicts of interest that may compromise impartiality.

  • Constructive feedback should be provided to help authors improve their manuscripts.

3. Responsibilities of Editors

  • Editors are responsible for fair and unbiased decision-making, regardless of author nationality, institutional affiliation, gender, or beliefs.

  • They must ensure that manuscripts are evaluated based on academic merit and relevance.

  • Editors are required to maintain confidentiality and avoid any conflict of interest.

  • The editorial team will act promptly in cases of misconduct, plagiarism, or ethical violations.

4. Research Ethics

  • Studies involving human subjects must follow the Declaration of Helsinki and obtain ethical approval from relevant institutional boards.

  • Research involving animals must comply with recognized international animal welfare standards.

  • Informed consent must be obtained where applicable, and participants’ privacy should always be respected.

5. Misconduct and Retraction

  • Any evidence of plagiarism, duplicate submission, data falsification, or unethical conduct will result in rejection or retraction of the article.

  • The journal will issue corrections, expressions of concern, or retractions in line with COPE guidelines.

6. Transparency and Accountability

  • Authors are encouraged to provide access to datasets, codes, and supplementary materials for transparency.

  • The journal promotes responsible research practices that contribute positively to science, technology, management, and pharmacy.